Amneal Pharmaceuticals, Inc.
$AMRX
Public valuation for Amneal Pharmaceuticals, Inc. (AMRX). Fair value, signal, and key metrics — no sign-in required.
Current Price
$13.17
29% Undervalued
Fair Value Estimate
$17
🏛️
Mature Growth
Profitable company with steady growth
Analyst Consensus
Target: $17.20
31% higher than current
Key Metrics
Market Cap
$4.2B
Forward P/E
16.3x
Operating Margin
19.6%
Revenue Growth
9.1%
Get free watchlist alerts
Join the waitlist for valuation updates on $AMRX and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.